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Background: Although considerable research on neuromuscular junctions (NMJs) has been 
conducted, the prospect of in vivo NMJ studies is limited and these studies are challenging to 
implement. Therefore, there is a clear unmet need to develop a feasible, robust, and physiologi-
cally relevant in vitro NMJ model.
Objective:  We aimed to establish a novel functional human NMJs platform, which is serum 
and neural complex media/neural growth factor-free, using human immortalized myoblasts and 
human embryonic stem cells (hESCs)-derived neural progenitor cells (NPCs) that can be used 
to understand the mechanisms of NMJ development and degeneration.
Methods: Immortalized human myoblasts were co-cultured with hESCs derived committed 
NPCs. Over the course of the 7 days myoblasts differentiated into myotubes and NPCs differ-
entiated into motor neurons. 
Results: Neuronal axon sprouting branched to form multiple NMJ innervation sites along 
the myotubes and the myotubes showed extensive, spontaneous contractile activity. Choline 
acetyltransferase and βIII-tubulin immunostaining confirmed that the NPCs had matured into 
cholinergic motor neurons. Postsynaptic site of NMJs was further characterized by staining 
dihydropyridine receptors, ryanodine receptors, and acetylcholine receptors by α-bungarotoxin.
Conclusion: We established a functional human motor unit platform for in vitro investigations. 
Thus, this co-culture system can be used as a novel platform for 1) drug discovery in the treat-
ment of neuromuscular disorders, 2) deciphering vital features of NMJ formation, regulation, 
maintenance, and repair, and 3) exploring neuromuscular diseases, age-associated degeneration 
of the NMJ, muscle aging, and diabetic neuropathy and myopathy.
Keywords: motor unit, neuromuscular junctions, human embryonic stem cells, neuronal pro-
genitor cells, human myoblasts
Introduction
Neuromuscular junctions (NMJs) serve as the interface between nerves and skeletal 
muscles. Maintenance, structure, and formation of NMJs depend on the bidirectional 
molecular interaction between the muscle and motor neuron.1 The NMJ consists of 
a presynaptic motor neuron terminal, a postsynaptic motor end plate and a synaptic 
cleft. If chemical or molecular communication is disrupted, NMJ deterioration can 
follow. This involves axon degeneration, synapse disruption, impaired NMJ transmis-
sion, and muscle fiber degradation2 which are the features of neuromuscular diseases, 
myopathies, and age-associated neuromuscular impairments.3
Despite decades of intensive research to characterize the structure and function of 
NMJs by utilizing animals and ex vivo models,4 effective treatment of neuromuscular 
Correspondence: nasser Al-Shanti
School of healthcare Science, Faculty 
of Science and engineering, Manchester 
Metropolitan University, John Dalton 
Building, Chester Street, M1 5gD 
Manchester, UK
Tel +44 161 247 5712
Fax +44 161 247 6831
email n.al-shanti@mmu.ac.uk
Journal name: Stem Cells and Cloning: Advances and Applications
Article Designation: Original Research
Year: 2018
Volume: 11
Running head verso: Abd Al Samid et al
Running head recto: A functional human motor unit platform
DOI: http://dx.doi.org/10.2147/SCCAA.S178562
 
St
em
 C
el
ls 
an
d 
Cl
on
in
g:
 A
dv
an
ce
s 
an
d 
Ap
pl
ica
tio
ns
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
17
8.
20
.1
90
.1
15
 o
n 
21
-N
ov
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Stem Cells and Cloning: Advances and Applications 2018:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
86
Abd Al Samid et al
and neurodegenerative diseases remains a significant unmet 
clinical need. This is mainly due to the failure of experimental 
animal models to reflect complex processes of human aging 
and disease progression.5 In order to advance this field, novel, 
alternative, experimental models are needed.
There has been recent progress toward the development 
of in vitro co-culture models using human induced pluripo-
tent stem cells (iPSCs);6,7 mouse,8 rat,9 and human primary 
myoblasts;10,11 and human embryonic stem cells (hESCs)12–14 
and cross-species models.15,16 However, existing in vitro 
motor neuron and skeletal muscle co-culture systems typi-
cally require a complex neural growth medium that contains 
serum and cocktails of around 15 neural growth factors 
(some of which are derived from animals).11,12,17 This further 
complicates drug discovery and toxicology studies due to 
possible cross-communication of the novel compound with 
factors contained within the added media, possibly explain-
ing why many promising therapies do not translate to clinics. 
Another issue with existing models is that muscle contrac-
tion is induced by applied electrical or chemical stimulation, 
which does not replicate the native physiological stimulation 
required for muscle contractions.8,17–19 Recent innovation in 
the use of iPSCs offers the potential to derive myoblasts and 
motor neurons for use with in vitro NMJ models. However, 
cells derived from iPSCs may exhibit genetic inconsistency 
and genetic modification, which limit their use.20 Recent 
human iPSC-based studies have failed to recapitulate the 
severe neuronal loss observed in human neurodegenerative 
diseases.21–23 Human skeletal myoblasts which were used in 
some of the abovementioned models10,11 were obtained from 
primary cells (eg, muscle biopsy or surgical samples), but 
their life span is limited to just a few passages which restricts 
experimentation and necessitates repeated supply of the pri-
mary cells.24,25 Furthermore, primary cells have varied cell 
purity26 and experience phenotypic changes when expanded, 
rendering primary myoblasts a problematic choice for a con-
sistently reproducible co-culture system.24,25 Therefore, there 
is a clear need for a more relevant human experimental model 
to study motor units and NMJs to overcome the limitations 
of existing models.
Methods
human immortalized myoblast cultures
The human immortalized myoblasts cell line (“C25”) was 
obtained from the Institute of Myology.27 This cell line was 
established using a biopsy of semi-tendinosis from a 25-year-
old male (obtained anonymously from Myobank, a tissue 
bank affiliated to EuroBioBank which is authorized by the 
French Ministry of Research [authorization AC-2013-1868]). 
After attaining 80% confluence, cells were seeded in six-
well plates recoated with gelatin (0.5%) at a concentration 
of 1.5×105 cells/mL in growth media. The growth media 
was supplemented with DMEM from Lonza (Basel, Swit-
zerland), 60% (v/v) Medium 199 with Earle’s Balanced Salt 
Solution from Lonza, 20% (v/v) heat-inactivated FBS from 
Thermo Fisher Scientific (Waltham, MA, USA), 20% (v/v) 
L-glutamine from Lonza, 1% (v/v) fetuin from FBS from 
Sigma-Aldrich (St Louis, MO, USA) 25 µg/mL, recombinant 
human basic fibroblast growth factor from Thermo Fisher 
Scientific 0.5 ng/mL, recombinant human EGF from Thermo 
Fisher Scientific 5 ng/mL, recombinant human hepatocyte 
growth factor from Sino Biological Inc. (Beijing, China) 
2.5 ng/mL, recombinant human insulin from Sigma-Aldrich 
5 µg/mL, dexamethasone from Sigma-Aldrich 0.2 µg/mL and 
gentamicin from Thermo Fisher Scientific.
neural differentiation of heSCs
induction of neuroepithelial clusters (neCs)
Mouse embryonic fibroblasts (MEFs; Cell Biolabs, San 
Diego, CA, USA) were cultured within MEF growth media 
(summarized in Table 1) and were passaged at a 1:4 ratio. At 
passage 4 (p4), MEFs were inactivated mitotically using 0.1 
µg/mL mitomycin C (Sigma-Aldrich). The Shef3 hESC line 
was obtained from the UK StemCell Bank under the project 
SCSC10-48 and maintained on mitotically inactivated MEFs 
Table 1 MeF growth media
MEF growth media components Volume
DMeM from lonza (Basel, Switzerland) 500 ml
l-glutamine from lonza 1% (v/v)
Penicillin/streptomycin (Sigma-Aldrich,  
St louis, MO, USA)
5 ml (2 mM)
Heat-inactivated FBS from Thermo Fisher Scientific 
(Waltham, MA, USA)
10% (v/v)
Abbreviation: MEF, mouse embryonic fibroblast.
Table 2 heSC media for cells on MeFs
hESC/MEF cell medium components Volume
DMeM-F12 (1:1) from lonza (Basel, Switzerland) 38.5 ml
MeM nonessential amino acids (Thermo Fisher 
Scientific, Waltham, MA, USA)
0.5 ml (1X)
Penicillin/streptomycin (Sigma-Aldrich, St louis, 
MO, USA)
0.5 ml (1X)
bFgF (r&D Systems, Minneapolis, Mn, USA) 
(100 µg/ml)
5 µl (10 ng/
ml)
Knockout serum replacement (Thermo Fisher 
Scientific)
10 ml (20%)
Abbreviations: bFGF, basic fibroblast growth factor; hESC, human embryonic 
stem cell; MEF, mouse embryonic fibroblast; MEM, Minimum Essential Medium.
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in hESC medium (summarized in Table 2) in 96-well plates. 
hESCs were mechanically passaged every 5–7 days and 
then conditioned to feeder-free culture by TrypLE Express 
(Thermo Fisher Scientific) enzyme dissociation and plated at 
a high density (1:1) onto hESC-qualified Matrigel® (Corning)-
coated flasks in mTESR (STEMCELL Technologies). For 
neural induction, feeder-free hESCs were dissociated with 
TrypLE and replated in neural induction medium (NIM; sum-
marized in Table 3) in uncoated, V-shaped 96-well plates at a 
density of 1×104 cells/well. Within 24 hours, NECs formed.
generation of neural rosette-forming progenitor 
cells (nrPCs)
Medium was replaced daily for 5 days. On day 6, aggregates 
were replated in 96-well plates in NIM onto 20 µg/mL laminin 
(Millipore)-coated dishes to allow neural rosette formation 
(2–3 days).
expansion of neural progenitor cells
Neural rosette clusters were mechanically isolated and 
replated in 96-well plates onto laminin-coated dishes in 
neural expansion medium (NIM plus 1X B27 supplement; 
Thermo Fisher Scientific). Early- and late-passage neural 
progenitor cells (NPCs) were cultured in the same conditions 
and passaged at a 1:3 ratio using TrypLE. To monitor NPCs 
differentiation into motor neurons, some of the NPCs were 
transfected with a GFP-reporter lentivirus system.
immunohistochemistry of neCs, nrPCs, and nPCs
For immunostaining, at each stage of neural differentiation 
(NECs and NRPCs), cells were sectioned onto glass slides. 
Sectioned NECs and NRPCs and cultured NPCs in six-well 
plates were fixed with 4% paraformaldehyde. Fixed sections 
and NPCs were permeabilized with 0.3% Triton X in PBS 
and then subsequently blocked with 2% BSA in PBS/Tween 
Table 3 neural induction medium
NIM components Volume
DMeM-F12 (1:1) from lonza (Basel, 
Switzerland)
48.5 ml
MeM nonessential amino acids (Thermo Fisher 
Scientific, Waltham, MA, USA)
0.5 ml (1X)
Penicillin/streptomycin (Sigma-Aldrich,  
St louis, MO, USA)
0.5 ml (1X)
bFgF (r&D Systems, Minneapolis, Mn, USA) 
(100 µg/ml)
10 µl (20 ng/ml)
N2 supplement (Thermo Fisher Scientific) 0.5 ml (1X)
heparin (Sigma-Aldrich) (2 mg/ml) 50 µl (2 µg/ml)
Poly (vinyl alcohol) (Sigma-Aldrich) 4 mg/ml
Abbreviations: bFGF, basic fibroblast growth factor; MEM, Minimum Essential 
Medium; niM, neural induction medium.
20. The slides were then incubated overnight at 4°C with a 
primary antibody (MAB2736; R&D Systems). The following 
day, sections and NPCs were washed with PBS and incubated 
for 1 hour at room temperature (RT) with goat anti-mouse 
secondary antibody (Alexa Flour 568-red for NECs, NRPCs 
and NPCs; Thermo Fisher Scientific) and imaged under a fluo-
rescent microscope (Leica CTR 6000; Leica Microsystems, 
Wetzlar, Germany).
Co-culture of nPCs and human 
myoblasts
Human myoblasts were incubated over 24 hours at 37°C 
within a 5% CO
2
 environment in six-well plates. Then, the 
growth media was replaced with co-culture media supple-
mented with DMEM (500 mL), 10 µg/mL recombinant 
human insulin, and 10 µg/mL gentamicin. NPCs were present 
at a concentration of 25×103 cells/mL and incubated at 37°C 
with 5% CO
2
 for up to 7 days. At day 7, myotube contrac-
tions were observed.
immunohistochemistry
At day 7, cells were stained with α-Bungarotoxin (α-BTX) 
(T0195, 1/200; Sigma-Aldrich), and then fixed with 4% 
paraformaldehyde for 10 minutes at RT. Co-cultures were 
washed twice with PBS (Thermo Fisher Scientific). After 
α-BTX staining, cells were washed twice with PBS and 
permeabilized with 1X perm/wash buffer (BD, Franklin 
Lakes, NJ, USA) for 30 minutes at RT. Cells were washed 
twice with PBS and then blocked with PBS containing 1% 
BSA and 10% goat serum (Thermo Fisher Scientific) for 1 
hour at RT. The following antibodies were used: mouse anti-
βIII-tubulin (MAB1195, clone #TuJ1, 1/400; R&D Systems), 
rabbit anti-ryanodine receptor (anti-RyR; AB9078, 1/200; 
Millipore), goat anti-choline acetyltransferase (anti-ChAT; 
ABN100, 1/200; Millipore), goat anti-ChAT (AB144, 1/200; 
Millipore), and mouse anti-dihydropyridine receptor (anti-
DHPR; Ab2864, 1/400; Abcam). These antibodies were incu-
bated overnight at 4°C in 1X perm/wash buffer. Co-cultures 
were washed with PBS and stained with the corresponding 
secondary antibodies supplemented with DAPI (1/10,000; 
Sigma-Aldrich) for 1 hour at RT. Stained co-culture cells 
were visualized using a Leica SP5 confocal microscope 
sourced by Leica Microsystems for fluorescent microscopy.
Results
A functional human motor unit platform
The present work describes a functional human motor unit 
platform established using immortalized skeletal myoblasts 
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and hESCs-derived NPCs that develop into motor neurons 
in muscle differentiation media (co-culture media) devoid of 
any complex neural growth factors or serum.
To validate the platform, two monoculture controls were 
included, one of NPCs and the other of immortalized human 
myoblasts27 with co-culture media for 7 days. Cultured GFP-
transfected NPCs did not show any morphological changes 
or motor neuron differentiation, but instead they deteriorated 
and died (Figure 1A). The human myoblasts stained with 
phalloidin-DAPI showed normal morphology and differentia-
tion features with centrally and peripherally located nuclei, 
but the myotubes did not spontaneously contract (Figure 1B).
Derivation of nPCs from heSCs and 
establishment of the nMJs model
The NPCs were derived from hESCs, as described previ-
ously.28 Neural differentiation of hESCs progressed through 
three stages of differentiation to NECs (Figure 2A) and 
NRPCs (Figure 2B) which were stained with Nestin red 
color. To confirm that differentiated NPCs were homogeneous 
committed neural lineage, cells were stained with DAPI, 
anti-GFAP (a specific marker for glial cells) and anti-Nestin. 
Double-positive staining (DAPI blue and Nestin red) con-
firmed the formation of NPCs while single DAPI staining was 
not observed, which confirmed that the differentiated cells 
were NPCs (Figure 2C). Staining of GFAP was not present, 
confirming again that all of the cells were NPCs (Figure 2C).
The NPCs were co-cultured with human immortalized 
myoblasts for 7 days in co-culture media. After myogenic 
differentiation was initiated, the characteristics of functional 
motor units began to develop. This included myotube forma-
tion and axonal sprouting from the NPCs which subsequently 
formed NMJs along the myotubes (Figure 2D). The myotubes 
showed spontaneous muscle contractions from approximately 
day 7 onwards in the absence of any exogenous electrical 
and chemical stimuli (Video S1). Due to the force of con-
tractions, some myotubes were detached from the culture 
plate, causing large spaces within the co-culture. Since the 
myotubes cultured without NPCs did not contract, they did 
not detach from the culture plate and did not open up large 
spaces (Figure 1B).
Characterization of co-cultures
On day 7, the motor neuron formation was assessed using the 
specific marker for motor neuron differentiation, βIII-tubulin. 
Figure 3A shows a typical shape of mature motor neurons 
with axons terminating on myotubes. To further confirm the 
formation of cholinergic motor neurons, acetyltransferase 
antibodies (ChAT, a key enzyme for acetylcholine biosyn-
thesis) were used and are shown in green in Figure 3B.
Neurally and aneurally cultured myotubes were character-
ized by antibody staining against DHPRs and RyRs voltage-
gated channels which are located at muscle fiber T-tubules 
and the sarcoplasmic reticulum, respectively. The DHPR- 
and RYR-stained images showed transversal triad structures 
(Figure 3C). These images illustrated mature differentiated 
myotubes within the co-culture platform with peripherally 
located nuclei (Figure 3A and B). The aneurally cultured 
myotubes (control image) differentiated as expected, but did 
not exhibit appropriate transversal triad structures (Figure 3D).
NMJs display acetylcholine receptor (AChR) clusters 
along myotubes, and these were assessed by staining for 
α-BTX, as shown in Figure 3B and E where AChRs are 
marked by red clusters. As shown in Figure 3A and E, motor 
neuron axons extend to innervate myotubes and AChR 
clusters at this same location, marked with α-BTX (red), 
Figure 1 Monoculture of nPCs (A) and myoblasts (B).
Notes: nPCs and myoblasts were separately cultured for 7 days. The same growth media was used for monocultures and co-cultures. (A) A representative image of gFP-
transfected nPCs. The nPCs did not exhibit any morphological changes or motor neuron differentiation; instead, they deteriorated and died. (B) A representative image of 
phalloidin-DAPi-stained human myoblasts showed normal morphology and differentiation features with centrally and peripherally located nuclei. Scale bar: 50 µM.
Abbreviation: nPC, neural progenitor cell.
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indicating NMJ formation. Spontaneous myotube contractile 
activity was determined on day 7. The myotubes co-cultured 
with motor neurons showed high levels of spontaneous con-
tractile activity (Video S1). Muscle contractions were absent 
from aneural myoblast cultures.
Discussion
implications and future uses
This report describes a novel functional human motor unit 
platform engineered from immortalized skeletal myoblasts 
and NPCs derived from hESCs. This unique platform was 
established for investigation of human NMJs and motor unit 
formation, maintenance, and disease, as well as for drug 
discovery and toxicity research.
The motor neuron and skeletal muscle co-cultures matured 
without adding complex cocktails of serum or neural growth 
factors. NMJ formation was observed and spontaneous myo-
tube contractions were recorded (Video S1) over a period as 
short as 6–7 days, which is very early compared with the 14 
days needed in previous studies16 or where NMJs formed after 
20–25 days.29 These are crucial advances for studying the 
basic aspects of development and for recognizing pathophysi-
ological systems of NMJ disorders associated with disease 
or aging. It is important that this type of work is carried out 
with relevant human cultures to increase the possibility for 
translation to clinical practice. Most previous cell culture 
model systems used cross-species cell types15,19 and required 
cocktails of serum30,31 and growth factors.10,17,19,29 These were 
absent from the present model without any adverse effects, 
which suggests that nerve and muscle cells release all of the 
necessary factors needed to stimulate nerve axonal sprouting 
and formation of NMJs with myotubes. Moreover, eliminat-
ing serum, which contains unknown factors that may affect 
assay reproducibility, simplifies the interpretation of pharma-
cology and toxicity studies.32 Functional NMJ formation is 
strongly supported by bidirectional communication1 between 
nerve and muscle as well as by neural growth factors (such 
as brain-derived neurotrophic factor, glial cell line-derived 
neurotrophic factor and neurotrophin-3/4) secreted by muscle 
to support NMJ formation, maturation and maintenance.33,34 
Future investigations using this model will identify key fac-
tors released from nerve and muscle to orchestrate axonal 
sprouting, localization, and NMJ maintenance.
Although animal models can represent essential parts of 
physiological changes in a human disease,35 in vitro human 
cell cultures offer many advantages because they are formed 
Figure 2 neural differentiation of heSCs.
Notes: Identification of NPCs from hESCs using Nestin red color as a specific neural differentiation marker. (A) neCs. (B) nrPCs. (C) nestin-red color for nPCs. (D) A 
representative phase-contrast image of nMJ formation showing an axon extended to contact a myotube. White dotted circle indicates a rosette shape. Scale bars are 100 
µM for images (A)–(C) and 25 µM for image (D).
Abbreviations: heSC, human embryonic stem cell; neC, neuroepithelial cluster; nMJ, neuromuscular junction; nPC, neural progenitor cell; nrPC, neural rosette-forming 
progenitor cell.
Motor neuron
A B
C D
Axon
Myotube
Neuromuscular
junction
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Figure 3 Characterization of muscle–nerve co-cultures.
Notes: (A and B) Characterization of motor neuron formation. (A) A representative image of the co-culture cells stained for βiii-tubulin (green) and DAPi (blue); scale bars: 
25 µm. (B) A representative image of the co-culture cells stained for ChAT (green), α-BTX (red), and DAPi (blue); scale bars: 75 µm. (C and D) Characterization of advanced 
differentiated myotubes. (C) A representative image of the co-culture cells stained for DhPr (red), ryr (green), and DAPi (blue); scale bars: 2.5 µm. (D) A representative 
image of the co-culture cells stained for DhPr (red), ryr (green), and DAPi (blue); scale bars: 7.5 µm. (E) Characterization of functional nMJs formation. A representative 
image of the co-culture cells stained for βiii-tubulin (TuJ1; green), α-BTX (red), and DAPi (blue); scale bars: 25 µm.
Abbreviations: α-BTX, α-bungarotoxin; ChAT, choline acetyltransferase; DhPr, dihydropyridine receptor; nMJ, neuromuscular junction; ryr, ryanodine receptor.
A
B
C
D
E
DAPI βIII-tubulin DAPIβIII-tubulin
DAPIβIII-tubulin
DAPI ChAT BTX
DAPI BTX βIII-tubulin
βIII-tubulin BTX DAPI
BTX
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of relevant cell types, they can be produced quickly for high-
throughput screening, and they are more cost-effective in 
comparison to animal models.10,17
Conclusion
In summary, human immortalized myoblasts were co-cultured 
with hESCs-derived NPCs. Over the course of 7 days, myo-
blasts differentiated into myotubes and NPCs sprouted axons 
that branched to form multiple NMJ innervation sites along 
myotubes, and myotubes showed extensive, spontaneous 
contractile activity. This cell culture platform may be used 
to study human NMJ growth and disease and may reduce the 
use of animal models in future related research.
Acknowledgment
This work was sponsored by the School of Healthcare 
Science, Faculty of Science and Engineering, Manchester 
Metropolitan University (Manchester, UK).
Author contributions
MAS, JSM, and NAS developed the study concept. All the 
authors contributed to methodology. MAS, JSM, and NAS 
carried out the investigation. JSM, TRM, and NAS supervised 
the study. MAS, JSM, and NAS wrote the original draft of 
the manuscript. MAS, JSM, VM, and NAS reviewed and 
edited the draft manuscript. All authors contributed to data 
analysis, drafting or revising the article, gave final approval 
of the version to be published, and agree to be accountable 
for all aspects of the work.
Disclosure
The authors report no conflicts of interest in this work.
References
 1. Zahavi EE, Ionescu A, Gluska S, Gradus T, Ben-Yaakov K, Perlson E. A 
compartmentalized microfluidic neuromuscular co-culture system reveals 
spatial aspects of GDNF functions. J Cell Sci. 2015;128(6):1241–1252.
 2. Gonzalez-Freire M, de Cabo R, Studenski SA, Ferrucci L. The Neuro-
muscular Junction: Aging at the Crossroad between Nerves and Muscle. 
Front Aging Neurosci. 2014;6:208.
 3. Zhou C, Wu L, Ni F, Ji W, Wu J, Zhang H. Critical illness poly-
neuropathy and myopathy: a systematic review. Neural Regen Res. 
2014;9(1):101–110.
 4. Wu H, Xiong WC, Mei L. To build a synapse: signaling pathways in neu-
romuscular junction assembly. Development. 2010;137(7):1017–1033.
 5. van der Worp HB, Howells DW, Sena ES, et al. Can animal models of 
disease reliably inform human studies? PLoS Med. 2010;7(3):e1000245.
 6. Thomson SR, Wishart TM, Patani R, Chandran S, Gillingwater TH. 
Using induced pluripotent stem cells (iPSC) to model human neuromus-
cular connectivity: promise or reality? J Anat. 2012;220(2):122–130.
 7. Berry BJ, Akanda N, Smith AS, et al. Morphological and functional 
characterization of human induced pluripotent stem cell-derived 
neurons (iCell Neurons) in defined culture systems. Biotechnol Prog. 
2015;31(6):1613–1622.
 8. Umbach JA, Adams KL, Gundersen CB, Novitch BG. Functional neu-
romuscular junctions formed by embryonic stem cell-derived motor 
neurons. PLoS One. 2012;7(5):e36049.
 9. Smith AS, Long CJ, Pirozzi K, Hickman JJ. A functional system for 
high-content screening of neuromuscular junctions in vitro. Technology. 
2013;1(1):37–48.
 10. Demestre M, Orth M, Föhr KJ, et al. Formation and characterisation 
of neuromuscular junctions between hiPSC derived motoneurons and 
myotubes. Stem Cell Res. 2015;15(2):328–336.
 11. Guo X, Colon A, Akanda N, et al. Tissue engineering the mecha-
nosensory circuit of the stretch reflex arc with human stem cells: 
Sensory neuron innervation of intrafusal muscle fibers. Biomaterials. 
2017;122:179–187.
 12. Guo X, Greene K, Akanda N, et al. In vitro Differentiation of Func-
tional Human Skeletal Myotubes in a Defined System. Biomater Sci. 
2014;2(1):131–138.
 13. Santhanam N, Kumanchik L, Guo X, et al. Stem cell derived phenotypic 
human neuromuscular junction model for dose response evaluation of 
therapeutics. Biomaterials. 2018;166:64–78.
 14. Happe CL, Tenerelli KP, Gromova AK, Kolb F, Engler AJ. Mechanically 
patterned neuromuscular junctions-in-a-dish have improved functional 
maturation. Mol Biol Cell. 2017;28(14):1950–1958.
 15. Arnold AS, Christe M, Handschin C. A functional motor unit in the 
culture dish: co-culture of spinal cord explants and muscle cells. J Vis 
Exp. 2012 (62):3616.
 16. Vilmont V, Cadot B, Ouanounou G, Gomes ER. A system for studying 
mechanisms of neuromuscular junction development and maintenance. 
Development. 2016;143(13):2464–2477.
 17. Guo X, Gonzalez M, Stancescu M, Vandenburgh HH, Hickman JJ. 
Neuromuscular junction formation between human stem cell-derived 
motoneurons and human skeletal muscle in a defined system. Bioma-
terials. 2011;32(36):9602–9611.
 18. Miles GB, Yohn DC, Wichterle H, Jessell TM, Rafuse VF, Brownstone 
RM. Functional properties of motoneurons derived from mouse embry-
onic stem cells. J Neurosci. 2004;24(36):7848–7858.
 19. Guo X, das M, Rumsey J, Gonzalez M, Stancescu M, Hickman J. 
Neuromuscular junction formation between human stem-cell-derived 
motoneurons and rat skeletal muscle in a defined system. Tissue Eng 
Part C Methods. 2010;16(6):1347–1355.
 20. Chin MH, Mason MJ, Xie W, et al. Induced pluripotent stem cells and 
embryonic stem cells are distinguished by gene expression signatures. 
Cell Stem Cell. 2009;5(1):111–123.
 21. Chung CY, Khurana V, Auluck PK, et al. Identification and rescue of 
α-synuclein toxicity in Parkinson patient-derived neurons. Science. 
2013;342(6161):983–987.
 22. Kondo T, Asai M, Tsukita K, et al. Modeling Alzheimer’s disease 
with iPSCs reveals stress phenotypes associated with intracellular 
Aβ and differential drug responsiveness. Cell Stem Cell. 2013;12(4): 
487–496.
 23. Sareen D, O’Rourke JG, Meera P, et al. Targeting RNA foci in iPSC-
derived motor neurons from ALS patients with a C9ORF72 repeat 
expansion. Sci Transl Med. 2013;5(208):ra149.
 24. Mouly V, Aamiri A, Périé S, et al. Myoblast transfer therapy: is there 
any light at the end of the tunnel? Acta Myol. 2005;24(2):128–133.
 25. Webster C, Blau HM. Accelerated age-related decline in replicative 
life-span of Duchenne muscular dystrophy myoblasts: implica-
tions for cell and gene therapy. Somat Cell Mol Genet. 1990;16(6): 
557–565.
 26. Kaur G, Dufour JM. Cell lines: Valuable tools or useless artifacts. 
Spermatogenesis. 2012;2(1):1–5.
 27. Mamchaoui K, Trollet C, Bigot A, et al. Immortalized pathological 
human myoblasts: towards a universal tool for the study of neuromus-
cular disorders. Skelet Muscle. 2011;1:34.
 28. Fitzpatrick LM, Hawkins KE, Delhove J, et al. NF-κB Activity Initi-
ates Human ESC-Derived Neural Progenitor Cell Differentiation 
by Inducing a Metabolic Maturation Program. Stem Cell Reports. 
2018;10(6):1766–1781.
 
St
em
 C
el
ls 
an
d 
Cl
on
in
g:
 A
dv
an
ce
s 
an
d 
Ap
pl
ica
tio
ns
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
17
8.
20
.1
90
.1
15
 o
n 
21
-N
ov
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Stem Cells and Cloning: Advances and Applications 2018:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
92
Abd Al Samid et al
 29. das M, Rumsey JW, Bhargava N, Stancescu M, Hickman JJ. A defined 
long-term in vitro tissue engineered model of neuromuscular junctions. 
Biomaterials. 2010;31(18):4880–4888.
 30. Zhou FM, Hablitz JJ. Layer I neurons of rat neocortex. I. Action potential 
and repetitive firing properties. J Neurophysiol. 1996;76(2):651–667.
 31. Walsh K, Megyesi J, Hammond R. Human central nervous system 
tissue culture: a historical review and examination of recent advances. 
Neurobiol Dis. 2005;18(1):2–18.
 32. Rumsey JW, das M, Stancescu M, Bott M, Fernandez-Valle C, Hickman 
JJ. Node of Ranvier formation on motoneurons in vitro. Biomaterials. 
2009;30(21):3567–3572.
 33. Funakoshi H, Belluardo N, Arenas E, et al. Muscle-derived neuro-
trophin-4 as an activity-dependent trophic signal for adult motor 
neurons. Science. 1995;268(5216):1495–1499.
 34. Henderson CE, Camu W, Mettling C, et al. Neurotrophins promote 
motor neuron survival and are present in embryonic limb bud. Nature. 
1993;363(6426):266–270.
 35. Jensen J, Hyllner J, Björquist P. Human embryonic stem cell technolo-
gies and drug discovery. J Cell Physiol. 2009;219(3):513–519.
 
St
em
 C
el
ls 
an
d 
Cl
on
in
g:
 A
dv
an
ce
s 
an
d 
Ap
pl
ica
tio
ns
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
17
8.
20
.1
90
.1
15
 o
n 
21
-N
ov
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Stem Cells and Cloning: Advances and Applications 2018:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Stem Cells and Cloning: Advances and Applications
Publish your work in this journal
Submit your manuscript here: https://www.dovepress.com/stem-cells-and-cloning-advances-and-applications-journal
Stem Cells and Cloning: Advances and Applications is an  international, 
peer-reviewed, open access journal. Areas of interest in stem cell 
research include: Embryonic cell stems; Adult stem cells;  Blastocysts; 
Cordblood stem cells; Stem cell transformation and culture; Therapeutic 
cloning; Umbilical cord blood and bone marrow cells; Laboratory, 
animal and human therapeutic studies; Philosophical and ethical issues 
related to stem cell research. This journal is indexed on CAS. The 
manuscript management system is completely online and includes a 
quick and fair peer-review system. Visit http://www.dovepress.com/
testimonials.php to read real quotes from published authors..
Dovepress
93
A functional human motor unit platform
Supplementary material
Video S1 Phase contrast video micrograph of innervated human myotube 
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